Cristina Dominguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cristina Dominguez has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Juan Ignacio Caicedo
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
3 shared publications - Mauricio Plata
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
3 shared publications - Andres Vasquez
Oncology, Mediadvance Clinical, Chihuahua, Mexico
2 shared publications - Carlos Gustavo Trujillo
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia
2 shared publications - Jose Gustavo Ramos
Department of Urology Oncology, National Cancer Institute of Colombia, Bogotá, Colombia
2 shared publications - Juan Guillermo Cataño
Faculty of Medicine Pontificia Universidad Javeriana Bogotá D.C. Colombia
2 shared publications
Latest Publications
- Open Access
- 30 December 2022
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (4) , 442-47
Tumores renales de pacientes con riñones en herradura: reporte de 2 casos clínicos
El riñón en herradura (RH) es la anomalía congénita de fusión renal más común. La incidencia del tumor de células renales en riñón en herradura es similar a la de los pacientes con riñones de estructura normal; en cambio, el riesgo de desarrollar cáncer de células transicionales aumenta entre 2 a 6 veces. La presencia de cualquier malformación renal puede cambiar el plan de tratamiento quirúrgico y se busca realizar una cirugía con preservación de órgano. Se describen 2 casos clínicos de tumores (carcinoma renal de células claras y tumor urotelial) en riñones en herradura llevados a heminefrectomía radical abierta y laparoscópica.
- 30 December 2022
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (4) , 442-47
Open AccessTumores renales de pacientes con riñones en herradura: reporte de 2 casos clínicos
El riñón en herradura (RH) es la anomalía congénita de fusión renal más común. La incidencia del tumor de células renales en riñón en herradura es similar a la de los pacientes con riñones de estructura normal; en cambio, el riesgo de desarrollar cáncer de células transicionales aumenta entre 2 a 6 veces. La presencia de cualquier malformación renal puede cambiar el plan de tratamiento quirúrgico y se busca realizar una cirugía con preservación de órgano. Se describen 2 casos clínicos de tumores (carcinoma renal de células claras y tumor urotelial) en riñones en herradura llevados a heminefrectomía radical abierta y laparoscópica.
- Open Access
- 28 September 2022
- Published by Instituto Mexicano del Seguro Social in Revista Urología Colombiana / Colombian Urology Journal
- Vol. 31 (03) , e116-e120
Biochemical Relapse in Low-risk Prostate Cancer Treated with Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy
Introduction For low-risk prostate cancer (PCa), curative treatment with radical prostatectomy (RP) can be performed, reporting a biochemical relapse-free survival rate (bRFS) at 5 and 7 years of 90.1% and 88.3%, respectively. Prostatic specific antigen (PSA), pathological stage (pT), and positive margins (R1) are significant predictors of biochemical relapse (BR). Even though pelvic lymphadenectomy is not recommended during RP, in the literature, it is performed in 34% of these patients, finding 0.37% of positive lymph nodes (N1). In this study, we aim to evaluate the 10-year bRFS in patients with low-risk PCa who underwent RP and extended pelvic lymph node dissection (ePLND). Methodology All low-risk patients who underwent RP plus bilateral ePLND at the National Cancer Institute of Colombia between 2006 and 2019 were reviewed. Biochemical relapse was defined as 2 consecutive increasing levels of PSA > 0.2 ng/mL. A descriptive analysis was performed using the STATA 15 software (Stata Corp., College Station, TX, USA), and the Kaplan-Meier curves and uni and multivariate Cox proportional hazard models were used for the survival outcome analysis. The related regression coefficients were used for the hazard ratio (HR), and, for all comparisons, a two-sided p-value ˂ 0.05 was used to define statistical significance. Results Two hundred and two patients met the study criteria. The 10-year bRFS for the general population was 82.5%, statistically related to stage pT3 (p = 0.047), higher Gleason grade group (GG) (p ≤ 0.001), and R1 (p ≤ 0.001), but not with N1. A total of 3.9% of the patients had N1; of these, 75% had R1, 25% GG2, and 37% GG3. Among the N0 (non-lymph node metástasis in prostate cáncer) patients, 31% of the patients had R1, 41% GG2, and 13% GG3. Conclusions Our bRFS was 82.5% in low-risk patients who underwent RP and ePLND. With higher pT, GG, and presence of R1, the probability of BR increased. Those with pN1 (pathologicaly confirmed positive lymph nodes) were not associated with bRFS, with a pN1 detection rate of 3.9%. Details: In low-risk PCa, curative treatment with RP can be performed, reporting a bRFS rate at 5 and 7 years of 90.1% and 88.3%, respectively. Despite the fact that pelvic lymphadenectomy is not recommended during RP in clinical guidelines, in the literature, it is performed in 34% of these patients, finding 0.37% of N1. In this study, we report the 10-year bRFS in patients with low-risk PCa who underwent surgery.
- 28 September 2022
- Published by Instituto Mexicano del Seguro Social in Revista Urología Colombiana / Colombian Urology Journal
- Vol. 31 (03) , e116-e120
Open AccessBiochemical Relapse in Low-risk Prostate Cancer Treated with Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy
Introduction For low-risk prostate cancer (PCa), curative treatment with radical prostatectomy (RP) can be performed, reporting a biochemical relapse-free survival rate (bRFS) at 5 and 7 years of 90.1% and 88.3%, respectively. Prostatic specific antigen (PSA), pathological stage (pT), and positive margins (R1) are significant predictors of biochemical relapse (BR). Even though pelvic lymphadenectomy is not recommended during RP, in the literature, it is performed in 34% of these patients, finding 0.37% of positive lymph nodes (N1). In this study, we aim to evaluate the 10-year bRFS in patients with low-risk PCa who underwent RP and extended pelvic lymph node dissection (ePLND). Methodology All low-risk patients who underwent RP plus bilateral ePLND at the National Cancer Institute of Colombia between 2006 and 2019 were reviewed. Biochemical relapse was defined as 2 consecutive increasing levels of PSA > 0.2 ng/mL. A descriptive analysis was performed using the STATA 15 software (Stata Corp., College Station, TX, USA), and the Kaplan-Meier curves and uni and multivariate Cox proportional hazard models were used for the survival outcome analysis. The related regression coefficients were used for the hazard ratio (HR), and, for all comparisons, a two-sided p-value ˂ 0.05 was used to define statistical significance. Results Two hundred and two patients met the study criteria. The 10-year bRFS for the general population was 82.5%, statistically related to stage pT3 (p = 0.047), higher Gleason grade group (GG) (p ≤ 0.001), and R1 (p ≤ 0.001), but not with N1. A total of 3.9% of the patients had N1; of these, 75% had R1, 25% GG2, and 37% GG3. Among the N0 (non-lymph node metástasis in prostate cáncer) patients, 31% of the patients had R1, 41% GG2, and 13% GG3. Conclusions Our bRFS was 82.5% in low-risk patients who underwent RP and ePLND. With higher pT, GG, and presence of R1, the probability of BR increased. Those with pN1 (pathologicaly confirmed positive lymph nodes) were not associated with bRFS, with a pN1 detection rate of 3.9%. Details: In low-risk PCa, curative treatment with RP can be performed, reporting a bRFS rate at 5 and 7 years of 90.1% and 88.3%, respectively. Despite the fact that pelvic lymphadenectomy is not recommended during RP in clinical guidelines, in the literature, it is performed in 34% of these patients, finding 0.37% of N1. In this study, we report the 10-year bRFS in patients with low-risk PCa who underwent surgery.
- Open Access
- 1 August 2018
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 44 (4) , 688-696
Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer
Keywords: Prostatic Neoplasms; Magnetic Resonance Imaging; Prostatectomy
- 1 August 2018
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 44 (4) , 688-696
Open AccessDiagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer
Keywords: Prostatic Neoplasms; Magnetic Resonance Imaging; Prostatectomy
- 23 February 2018
- Published by Taylor & Francis in Acta Chirurgica Belgica
- Vol. 118 (6) , 348-353
Urological approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a clinical care center
Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is associated with significant manipulation of the urinary tract (UT). We aim to describe the urological events and their management in patients who underwent CRS-HIPEC. Methods: Clinical records of patients who underwent treatment between 2007 and 2015 were reviewed. Urological events and their multidisciplinary management were analyzed. Descriptive statistics were calculated. Results: A total of 103 patients were included. Mean age was 51 years (SD ± 11.8). Mean peritoneal cancer index (PCI) was 20.4 (SD ± 10.1). Primary tumors included appendicular (64%), gynecological (16%), colorectal (10%), and peritoneal mesotheliomas (9%). Ninety-three percent of patients had bilateral ureteral catheters inserted prior to surgery, without complications. Intraoperative UT injuries occurred in 7% of patients. In 5% of patients, tumor invasion of the bladder was evident at surgery and partial resection and primary repair of the bladder wall was performed. Urological complications included urinary tract infection (UTI) (21%) acute post-renal failure (4%), urinary fistulae (4%), and acute urinary retention (AUR) (1%). Conclusions: In our study, intraoperative UT events and postoperative complications, although not neglectable, were infrequent. Due to the high complexity of these cases, a multidisciplinary approach is mandatory. However, randomized clinical trials are necessary to clarify current data on the need and efficacy of prophylactic ureteral catheterization in patients undergoing CRS-HIPEC.
- 23 February 2018
- Published by Taylor & Francis in Acta Chirurgica Belgica
- Vol. 118 (6) , 348-353
Urological approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a clinical care center
Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is associated with significant manipulation of the urinary tract (UT). We aim to describe the urological events and their management in patients who underwent CRS-HIPEC. Methods: Clinical records of patients who underwent treatment between 2007 and 2015 were reviewed. Urological events and their multidisciplinary management were analyzed. Descriptive statistics were calculated. Results: A total of 103 patients were included. Mean age was 51 years (SD ± 11.8). Mean peritoneal cancer index (PCI) was 20.4 (SD ± 10.1). Primary tumors included appendicular (64%), gynecological (16%), colorectal (10%), and peritoneal mesotheliomas (9%). Ninety-three percent of patients had bilateral ureteral catheters inserted prior to surgery, without complications. Intraoperative UT injuries occurred in 7% of patients. In 5% of patients, tumor invasion of the bladder was evident at surgery and partial resection and primary repair of the bladder wall was performed. Urological complications included urinary tract infection (UTI) (21%) acute post-renal failure (4%), urinary fistulae (4%), and acute urinary retention (AUR) (1%). Conclusions: In our study, intraoperative UT events and postoperative complications, although not neglectable, were infrequent. Due to the high complexity of these cases, a multidisciplinary approach is mandatory. However, randomized clinical trials are necessary to clarify current data on the need and efficacy of prophylactic ureteral catheterization in patients undergoing CRS-HIPEC.
- 8 April 2017
- Published by Elsevier in Radiography
- Vol. 23 (3) , e62-e64
Spontaneous gastric rupture after Sodium Bicarbonate consumption: A case report
- 8 April 2017
- Published by Elsevier in Radiography
- Vol. 23 (3) , e62-e64
Spontaneous gastric rupture after Sodium Bicarbonate consumption: A case report
- Open Access
- 1 May 2016
- Published by Oxford University Press (OUP) in BJR|case reports
- Vol. 2 (2) , 20150261
Extramammary Paget’s disease
The purpose of this report is to describe an unusual case of extramammary Paget’s disease with urethral and lymph node infiltration and demonstrate the role of MRI in the pre-operative period for the assessment, management and prognosis of the disease. Although skin wrinkles on MRI may be misinterpreted based on observer's experience, it correlates well with pathology and may provide an accurate assessment before interventional therapy.
- 1 May 2016
- Published by Oxford University Press (OUP) in BJR|case reports
- Vol. 2 (2) , 20150261
Open AccessExtramammary Paget’s disease
The purpose of this report is to describe an unusual case of extramammary Paget’s disease with urethral and lymph node infiltration and demonstrate the role of MRI in the pre-operative period for the assessment, management and prognosis of the disease. Although skin wrinkles on MRI may be misinterpreted based on observer's experience, it correlates well with pathology and may provide an accurate assessment before interventional therapy.
- 1 November 2015
- Published by SAGE Publications in Journal of Endourology
- Vol. 29 (11) , 1253-1257
Photoselective Vaporization with KTP 180-W Green Laser for the Treatment of Lower Urinary Symptoms Secondary to Benign Prostatic Enlargement: Effectiveness and Safety at Midterm Follow-Up
To determine safety, efficacy, and improvement in patient's quality of life (QoL) with 180-W green light laser prostate photovaporization in medium-term follow-up. Observational descriptive analysis. All the patients who were treated with photoselective vaporization with potassium titanyl phosphate crystal 180-W green laser between January 2012 and February 2014 were included. The primary outcome was the change of the International Prostate Symptom Score (IPSS). A descriptive analysis was conducted. Statistic inference was made using nonparametric measurements according to the findings. The Wilcoxon signed-rank test was applied to paired data. Finally, survival curves were used to determine the effectiveness. Two hundred one subjects were included. The mean follow-up was 13.1 months (2-28). Prostate volume was 75.46 ml (30-240). Mean surgical time was 73.29±29.74 minutes, laser time was 44.27±21.03 minutes, and the mean energy used was 271.5±140.1 kJ. Postoperative indwelling catheter time was 15.81±8.87 hours. IPSS decreased 12.79 points, from 19.13±7.79 to 6.34±5.91 (p=0.0001). QoL question of the IPSS shows improvement from 4.16 to 1.27 (p=0.00001). In a maximum follow-up period of 28 months, 85.2% of patients showed an improvement of four points in IPSS. Visual scale of improvement perception showed an increase from 36.49 to 89.84 (p=0.0001). No major complications were reported. Prostate photoselective vaporization with a 180-W green light laser is a safe and effective treatment option for patients with lower urinary symptoms secondary to benign prostate enlargement.
- 1 November 2015
- Published by SAGE Publications in Journal of Endourology
- Vol. 29 (11) , 1253-1257
Photoselective Vaporization with KTP 180-W Green Laser for the Treatment of Lower Urinary Symptoms Secondary to Benign Prostatic Enlargement: Effectiveness and Safety at Midterm Follow-Up
To determine safety, efficacy, and improvement in patient's quality of life (QoL) with 180-W green light laser prostate photovaporization in medium-term follow-up. Observational descriptive analysis. All the patients who were treated with photoselective vaporization with potassium titanyl phosphate crystal 180-W green laser between January 2012 and February 2014 were included. The primary outcome was the change of the International Prostate Symptom Score (IPSS). A descriptive analysis was conducted. Statistic inference was made using nonparametric measurements according to the findings. The Wilcoxon signed-rank test was applied to paired data. Finally, survival curves were used to determine the effectiveness. Two hundred one subjects were included. The mean follow-up was 13.1 months (2-28). Prostate volume was 75.46 ml (30-240). Mean surgical time was 73.29±29.74 minutes, laser time was 44.27±21.03 minutes, and the mean energy used was 271.5±140.1 kJ. Postoperative indwelling catheter time was 15.81±8.87 hours. IPSS decreased 12.79 points, from 19.13±7.79 to 6.34±5.91 (p=0.0001). QoL question of the IPSS shows improvement from 4.16 to 1.27 (p=0.00001). In a maximum follow-up period of 28 months, 85.2% of patients showed an improvement of four points in IPSS. Visual scale of improvement perception showed an increase from 36.49 to 89.84 (p=0.0001). No major complications were reported. Prostate photoselective vaporization with a 180-W green light laser is a safe and effective treatment option for patients with lower urinary symptoms secondary to benign prostate enlargement.
- Open Access
- 1 June 2015
- Published by Pediatric Urology Case Reports in Pediatric Urology Case Reports
- Vol. 2 (4) , 25
Scrotal approach for the correction of an abdominoscrotal hydrocele: Medium term follow-up
Scrotal approach for the correction of an abdominoscrotal hydrocele: Medium term follow-up
- 1 June 2015
- Published by Pediatric Urology Case Reports in Pediatric Urology Case Reports
- Vol. 2 (4) , 25
Open AccessScrotal approach for the correction of an abdominoscrotal hydrocele: Medium term follow-up
Scrotal approach for the correction of an abdominoscrotal hydrocele: Medium term follow-up
- Open Access
- 25 September 2014
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 2 (3) , e38
Sexual and Reproductive Health for Young Adults in Colombia: Teleconsultation Using Mobile Devices
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.
- 25 September 2014
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 2 (3) , e38
Open AccessSexual and Reproductive Health for Young Adults in Colombia: Teleconsultation Using Mobile Devices
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.